ADC

The announcement of the ADC is the culmination of a series of talks between the leaders to put up a united front in the 2027 election, rather than splitting their vote.

At the unveiling of the ADC, interim chairman David Mark said it was an attempt to save the country’s democracy and to stop Nigeria from becoming a one-party state.

The ADC works by using the antibody to seek out the cancer cells that express TRBC1.

Then, those cancer cells ingest the ADC, where SG3249 is released and kills the cancer cells.

Tushar Nichakawade, first author on the study and a fourth-year Ph.D. student at the Ludwig Center, says, "There are so many lessons to learn from the clinic and it has been exciting to be a part of the iterative process of drug discovery. Every therapy has its pros and cons, but the preclinical efficacy of our ADC gives me hope that it can make a difference for patients suffering from these terrible cancers."